| Literature DB >> 19063738 |
Lennart Welin1, Annika Adlerberth, Kenneth Caidahl, Henry Eriksson, Per-Olof Hansson, Saga Johansson, Annika Rosengren, Kurt Svärdsudd, Catharina Welin, Lars Wilhelmsen.
Abstract
BACKGROUND: Random samples of 50-year-old men living in Gothenburg have been examined every 10th year since 1963 with a focus on cardiovascular risk factors. The aims of the study were to acquire up-to-date information about risk factors in the fifth cohort of 50-year-old men and women, to re-examine those who were 50 years of age in 1993, and to analyse the prevalence of the metabolic syndrome (MetSyn) using different definitions.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19063738 PMCID: PMC2621201 DOI: 10.1186/1471-2458-8-403
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Three definitions of the metabolic syndrome.
| At least 3 of the following: | At least 3 of the following: | Waist circumference (Euripides) ≥ 94 cm (men), ≥ 80 cm (women) plus any 2 of the following: |
| 1. Fasting P-glucose ≥ 6.1 mmol/l (≥ 110 mg/dl) | 1. Fasting P-glucose ≥ 5.6 mmol/l (≥ 100 mg/dl) or drug treatment for elevated glucose. | 1. Fasting p-glucose ≥ 5.6 mmol/l (≥ 100 mg/dl) or known type 2 diabetes |
| 2. Blood pressure ≥ 130/≥ 85 | 2. Systolic BP ≥ 130 or diastolic BP ≥ 85 or treatment for hypertension | 2. Systolic BP ≥ 130 and/or diastolic BP ≥ 85 or treatment for hypertension |
| 3. Triglycerides ≥ 1.7 mmol/l (≥ 150 mg/dl) | 3. Triglycerides ≥ 1.7 mmol/l (≥ 150 mg/dl) or drug treatment for elevated triglycerides | 3. Triglycerides ≥ 1.7 mmol/l (≥ 150 mg/dl) or specific treatment |
| 4. HDL-cholesterol <1.03 mmol/l (<40 mg/dl, men) or <1.29 mmol/l (<50 mg/dl, women) | 4. HDL-cholesterol <1.03 mmol/l (<40 mg/dl, men) or <1.29 mmol/l (<50 mg/dl, women) or drug treatment for low HDL-cholesterol | 4. HDL-cholesterol <1.03 mmol/l (<40 mg/dl, men) or <1.29 mmol/l (<50 mg/dl, women) or specific treatment |
| 5. Waist circumference >102 cm (men), >88 cm (women) | 5. Waist circumference ≥ 102 cm (men), ≥ 88 cm (women) |
Demographic data, self reported diseases, family history, and life style habits (%).
| n = 595 | n = 667 | n = 655 | |
| Married/cohabiting | 71.6 | 62.5 | 76.2 |
| Divorced | 13.5 | 19.7 | 11.2 |
| University/college | 35.4 | 42.5 | 28.1 |
| Workinga | 82.2 | 72.8 | 65.5 |
| Retired | 4.7 | 8.6 | 16.8 |
| Self-employed | 21.4 | 6.5 | 23.1 |
| Born in Sweden | 77.0 | 76.7 | 84.4 |
| Born in Europeb | 12.3 | 17.4 | 12.5 |
| Born outside Europe | 10.8 | 5.9 | 3.1 |
| Myocardial infarction | 1.2 | 0.5 | 6.7 |
| Coronary by-pass surgery | 0.8 | 0 | 3.4 |
| Percutaneous coronary intervention | 0.3 | 0.2 | 3.8 |
| Atrial fibrillationc | 1.0 (0.7) | 0.2 (0.2) | 4.4 (1.1) |
| Stroke | 0 | 0.5 | 2.4 |
| Family history of myocardial infarctiond | 35.5 | 38.2 | 35.9 |
| Family history of stroked | 25.0 | 27.3 | 26.4 |
| Family history of diabetesd | 25.0 | 23.2 | 24.0 |
| Regular smokers | 21.5 | 26.1 | 15.1 |
| Ex-smokers | 41.0 | 36.3 | 47.8 |
| Snuff, daily use | 18.7 | 2.9 | 16.8 |
| Ex-snuffers | 15.9 | 2.4 | 9.3 |
| Coffee daily | 89.1 | 93.4 | 96.6 |
| Continuous stresse | 17.3 | 22.8 | 10.3 |
| No physical exercise, leisure time | 17.7 | 13.8 | 11.6 |
| Physical exercise, leisure timef | 23.7 | 23.9 | 23.8 |
aFull time or part time work bOutside Sweden cFigures within parenthesis are the frequencies of atrial fibrillation recorded at the examination dThe family history among fathers or mothers or siblings as reported by the participants eContinuous stress as reported by the participant during the last year or up to the last 5 years fRegular or intense
Anthropometric data (means and standard deviation) and cut-off levels for body mass index (BMI), waist circumference and waist/hip ratio.
| Variable | |||
| Height (cm) | 179 (7) | 166 (7) | 178 (7) |
| Weight (kg) | 85.6 (13.3) | 70.5 (13.0) | 86.3 (12.9) |
| BMI (kg/m2) | 26.6 (3.7) | 25.6 (4.5) | 27.1 (3.7) |
| Waist (cm) | 94.5 (9.9) | 83.1 (11.4) | 97.0 (10.0) |
| Hip (cm) | 101.3 (6.6) | 99.7 (9.1) | 102.0 (6.5) |
| Waist/hip ratio | 0.93 (0.06) | 0.83 (0.07) | 0.95 (0.06) |
| BMI ≥ 25 (%) | 63.4 | 45.9 | 71.6 |
| BMI ≥ 30 (%) | 15.3 | 15.1 | 16.6 |
| Waist ≥ 80 cm (%) | 95.1 | 56.1 | 98.2 |
| Waist ≥ 88 cm (%) | 76.6 | 29.8 | 84.0 |
| Waist ≥ 94 cm (%) | 51.3 | 16.5 | 60.5 |
| Waist ≥ 102 cm (%) | 21.7 | 7.2 | 29.8 |
| Waist/hip ratio >0.85 (%) | 91.9 | 37.6 | 95.9 |
| Waist/hip ratio >0.90 (%) | 72.6 | 15.0 | 78.8 |
Blood pressure levels (means and standard deviation), the prevalence of hypertension and drug treatment for hypertension. Prevalence of diabetes and increased fasting plasma glucose.
| Variable | |||
| SBP, mm Hg, automatic | 129.3 (17.8) | 123.1 (19.0) | 139.8 (21.0) |
| SBP, mm Hg, physician | 134.7 (17.6) | 130.7 (18.6) | 143.8 (19.6) |
| DBP, mm Hg, automatic | 83.9 (10.9) | 82.6 (10.8) | 85.1 (11.3) |
| DBP, mm Hg, physician | 84.9 (10.4) | 80.8 (10.2) | 85.2 (10.5) |
| Drugs for hypertension (%) | 7.1 | 9.6 | 22.5 |
| Hypertension (%) | 46.2 | 36.0 | 66.7 |
| Known diabetes (%) | 4.0 | 2.0 | 6.4 |
| Fp-glucose ≥ 6.1 mmol/l (%) | 10.2 | 4.2 | 17.0 |
| Fp-glucose ≥ 5.6 mmol/l (%) | 26.1 | 10.4 | 32.6 |
SBP = systolic blood pressure. DBP = diastolic blood pressure phase 5. Hypertension was defined as a physicians diagnosis of hypertension and/or SBP ≥ 140 and/or DBP ≥ 90 (physician measurement), and/or treatment for hypertension.
Fp = fasting, plasma. Fp-glucos ≥ 6.1 and ≥ 5.6 respectively includes those with known diabetes.
To convert p-glucose from mmol/l to mg/dl multiply by 18.
Known diabetes = those who have been told by their doctors that they have diabetes
Lipids (means and standard deviation) and prevalence of hyperlipidaemia/dyslipidaemia using various cut-off points. Treatment for hyperlipidaemia.
| Variable | |||
| S-cholesterol mmol/l | 5.50 (1.01) | 5.44 (0.93) | 5.38 (0.93) |
| HDL-cholesterol mmol/l | 1.45 (0.38) | 1.85 (0.45) | 1.52 (0.39) |
| LDL-cholesterol mmol/l | 3.31 (0.87) | 3.05 (0.88) | 3.18 (0.83) |
| S-triglycerides mmol/l | 1.71 (1.18) | 1.24 (1.14) | 1.54 (0.92) |
| S-cholesterol <4.0 (%) | 4.7 | 2.9 | 5.1 |
| S-cholesterol ≥ 5.0 (%) | 69.4 | 69.5 | 67.1 |
| S-cholesterol ≥ 6.0 (%) | 32.4 | 24.6 | 26.0 |
| HDL-cholesterol ≤ 1.0 (%) | 11.8 | 1.4 | 8.0 |
| HDL-cholesterol ≥ 1.6 (%) | 34.1 | 73.4 | 40.4 |
| LDL-cholesterol ≤ 2.0 (%) | 6.9 | 11.5 | 8.6 |
| LDL-cholesterol ≥ 4.0 (%) | 22.8 | 14.2 | 18.7 |
| S-triglycerides ≥ 1.7 (%) | 38.2 | 17.3 | 22.4 |
| Treatment, drugs (%) | 3.9 | 2.9 | 14.5 |
| Treatment, diet only (%) | 2.2 | 2.4 | 4.1 |
S = serum. HDL = high-density lipoprotein. LDL = low-density lipoprotein.
To convert cholesterol from mmo/l to mg/dl multiply by 38.7.
To convert triglycerides from mmol/l to mg/dl multiply by 88.6
Figure 1Prevalence (%) of the metabolic syndrome using three definitions.
Figure 2The frequency distribution (%) in relation to number of risk factors (smoking, hypertension, dyslipidaemia, obesity and increased fasting blood glucose/diabetes) in the three cohorts.